Figure 1.
Outcomes for clinical trial vs off-label patients. (A) Median response duration for off-trial venetoclax patients (blue) compared with clinical trial patients (red). (B) Median OS for off-trial venetoclax patients (blue) compared with clinical trial patients (red).